""Meanwhile, GlaxoSmithKline is reminding folks that its antiflu med Relenza is a "preferred medication" for this year's influenza subtypes. And it has "ample supplies" of the drug available."
Looks like the "settlement" has prompted GSK to start pushing Relenza through all circles.
PortableAlpha, you are one hell of a comedian, but don't quit your day job. Did GSK announce a better inhaler? Injectable trials? They sure have seen the error of their way. We taught them a lesson they'll never forget.They respect us now. LOL.
LANI is also getting mentioned, I wonder if GSK will push to get worldwide rights to LANI?
That would be wonderful. We could celebrate our relationship with GSK every twenty years by suing them for failing to support a Biota invention. The fifth columnists on the board could put us in our place again. It would be perfect if Peter Cook was till CEO. Happy times.
Add to My Watchlist
What is My Watchlist?